Position in EOLS
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$38,878,025
+$12,669,143 QoQ
Shares Held
5,602,021
-12.2% QoQ
Ownership
8.48%
of shares outstanding
% of Portfolio
2.37%
of 13F equity value
Holder Rank
#1
of 158 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Derivatives in EOLS
reported options exposure · as of Jun 30, 2025CallValue
$921,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Nantahala Capital Management, LLC holds $169,874,929 across 9 Drug Manufacturers - Specialty & Generic names. EOLS ranks #3 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ETON |
Eton Pharmaceuticals, Inc.
|
1,175,951 | $42,569,426 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
2,268,751 | $39,272,079 | |
| 3 | EOLS |
Evolus, Inc.
This page
|
5,602,021 | $38,878,025 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,901,160 | $19,011,600 | |
| 5 | ADCT |
ADC Therapeutics SA
|
12,326,184 | $13,189,016 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
486,684 | $8,740,844 | |
| 7 | TLPH |
Talphera, Inc.
|
3,492,519 | $3,597,294 | |
| 8 | AYTU |
Aytu Biopharma, Inc
|
1,086,812 | $2,336,645 |
All Filings in EOLS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,878,025 | 5,602,021 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $26,208,882 | 6,376,857 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,707,315 | 5,820,649 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $35,162,901 | 5,726,857 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,662,898 | 4,197,926 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $921,000 | 100,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $1,203,000 | 100,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $43,925,656 | 3,651,343 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $34,556,844 | 3,130,149 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $45,762,553 | 2,824,849 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,582,711 | 2,910,849 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $40,751,886 | 2,910,849 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $30,651,239 | 2,910,849 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,849,950 | 421,220 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||